Mumford Sunni L, Kim Sungduk, Chen Zhen, Boyd Barr Dana, Buck Louis Germaine M
Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Department of Health and Human Services, Bethesda, MD; and
Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Department of Health and Human Services, Bethesda, MD; and.
J Nutr. 2015 Nov;145(11):2535-41. doi: 10.3945/jn.115.214973. Epub 2015 Sep 30.
Phytoestrogens have been associated with subtle hormonal changes, although effects on male fecundity are largely unknown.
We evaluated associations between male urinary phytoestrogen (isoflavone and lignan) concentrations and semen quality.
This study was a prospective cohort study of 501 male partners of couples desiring pregnancy and discontinuing contraception. Each participant provided up to 2 semen samples that were analyzed for 35 semen quality endpoints the following day. Linear mixed-effects models were used to estimate associations between baseline urinary phytoestrogen concentrations and semen quality parameters, adjusted for age, body mass index (BMI), research site, and serum lipid and cotinine concentrations.
Most associations between urinary phytoestrogens and semen quality parameters were null. However, select individual phytoestrogens were associated with semen quality parameters, with associations dependent on the class of phytoestrogens and modified by BMI. Specifically, genistein and daidzein were associated with a lower percentage of normal sperm and increased abnormalities in semen morphology, with reduced associations observed as BMI increased (P < 0.05) [percentages (95% CIs) of normal morphology by WHO traditional criteria: genistein, main effect: -5.61% (-9.42%, -1.79%); interaction: 0.19% (0.06%, 0.31%) per log unit increase; daidzein, main effect: -5.35% (-9.36%, -1.34%); interaction: 0.18% (0.05%, 0.32%) per log unit increase]. Enterolactone was associated with fewer abnormalities in semen morphometry and morphology and decreased DNA fragmentation, with reduced associations observed as BMI increased (P < 0.05) [percentages (95% CIs) of abnormalities in the neck and midpiece: enterolactone, main effect: -3.35% (-6.51%, -0.19%); interaction: 0.11% (0.01%, 0.21%) per log unit increase].
These results suggest that male urinary phytoestrogen concentrations characteristic of the US population may be associated with subtle indicators of male fecundity and semen quality but were not associated with couple fecundity.
植物雌激素与细微的激素变化有关,尽管其对男性生育能力的影响在很大程度上尚不清楚。
我们评估了男性尿液中植物雌激素(异黄酮和木脂素)浓度与精液质量之间的关联。
本研究是一项对501名希望怀孕并停止避孕的夫妇中的男性伴侣进行的前瞻性队列研究。每位参与者提供多达2份精液样本,次日对其进行35项精液质量指标的分析。采用线性混合效应模型来估计基线尿液中植物雌激素浓度与精液质量参数之间的关联,并对年龄、体重指数(BMI)、研究地点以及血清脂质和可替宁浓度进行了调整。
尿液中植物雌激素与精液质量参数之间的大多数关联均无统计学意义。然而,特定的个别植物雌激素与精液质量参数有关,其关联取决于植物雌激素的类别,并受到BMI的影响。具体而言,染料木黄酮和大豆苷元与正常精子百分比降低以及精液形态异常增加有关,随着BMI的增加,这种关联减弱(P<0.05)[按照世界卫生组织传统标准,正常形态的百分比(95%置信区间):染料木黄酮,主效应:-5.61%(-9.42%,-1.79%);交互作用:每增加一个对数单位增加0.19%(0.06%,0.31%);大豆苷元,主效应:-5.35%(-9.36%,-1.34%);交互作用:每增加一个对数单位增加0.18%(0.05%,0.32%)]。肠内酯与精液形态测量和形态异常减少以及DNA碎片减少有关,随着BMI的增加,这种关联减弱(P<0.05)[颈部和中段异常的百分比(95%置信区间):肠内酯,主效应:-3.35%(-6.51%,-0.19%);交互作用:每增加一个对数单位增加0.11%(0.01%,0.21%)]。
这些结果表明,美国人群特有的男性尿液中植物雌激素浓度可能与男性生育能力和精液质量的细微指标有关,但与夫妇生育能力无关。